La maladie de Parkinson en France (serveur d'exploration) - Corpus (PubMed)

Index « MedMesh.i » - entrée « Piribedil »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Piperidines < Piribedil < Pituitary Neoplasms  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 17.
Ident.Authors (with country if any)Title
000735 (2013) Stéphane Thobois ; Eugénie Lhommée ; Hélène Klinger ; Claire Ardouin ; Emmanuelle Schmitt ; Amélie Bichon ; Andrea Kistner ; Anna Castrioto ; Jing Xie ; Valerie Fraix ; Pierre Pelissier ; Stephan Chabardes ; Patrick Mertens ; Jean-Louis Quesada ; Jean-Luc Bosson ; Pierre Pollak ; Emmanuel Broussolle ; Paul KrackParkinsonian apathy responds to dopaminergic stimulation of D2/D3 receptors with piribedil.
000976 (????) Aurore Gouraud ; Anne Millaret ; Jacques Descotes ; Thierry VialPiribedil-induced sleep attacks in patients without Parkinson disease: a case series.
000A32 (2010) Mark J. MillanFrom the cell to the clinic: a comparative review of the partial D₂/D₃receptor agonist and α2-adrenoceptor antagonist, piribedil, in the treatment of Parkinson's disease.
000B07 (2010) Olivier Rascol ; Jean-Philippe Azulay ; Olivier Blin ; Anne-Marie Bonnet ; Christine Brefel-Courbon ; Pierre Césaro ; Philippe Damier ; Bérengère Debilly ; Frank Durif ; Monique Galitzky ; Jean-Marie Grouin ; Sylvie Pennaforte ; Gabriel Villafane ; Sadek Yaici ; Yves AgidOrodispersible sublingual piribedil to abort OFF episodes: a single dose placebo-controlled, randomized, double-blind, cross-over study.
000E25 (2006) Olivier Rascol ; Bruno Dubois ; Alexandre Castro Caldas ; Stephen Senn ; Susanna Del Signore ; Andrew LeesEarly piribedil monotherapy of Parkinson's disease: A planned seven-month report of the REGAIN study.
000E28 (2006) Mauricette Brocco ; Anne Dekeyne ; Mariusz Papp ; Mark J. MillanAntidepressant-like properties of the anti-Parkinson agent, piribedil, in rodents: mediation by dopamine D2 receptors.
000E32 (2006) Nathalie Turle-Lorenzo ; Béatrice Maurin ; Carole Puma ; Claire Chezaubernard ; Philippe Morain ; Christelle Baunez ; André Nieoullon ; Marianne AmalricThe dopamine agonist piribedil with L-DOPA improves attentional dysfunction: relevance for Parkinson's disease.
000F40 (2005) Nicolas Simon ; Joëlle Micallef ; Jean-Charles Reynier ; Monique Lesourd ; Tatiana Witjas ; André Alicherif ; Jean-Philippe Azulay ; Olivier BlinEnd-of-dose akinesia after a single intravenous infusion of the dopaminergic agonist piribedil in Parkinson's disease patients: a pharmacokinetic/pharmacodynamic, randomized, double-blind study.
001112 (2003) Marc Ziegler ; Alexandre Castro-Caldas ; Susanna Del Signore ; Olivier RascolEfficacy of piribedil as early combination to levodopa in patients with stable Parkinson's disease: a 6-month, randomized, placebo-controlled study.
001146 (2003) N V Fedorova[Use of pronoran (piribedil) in Parkinson's disease: the results of a multicenter study].
001176 (2002) Anne-Marie Bonnet[Alpha-2 adrenergic receptors and Parkinson's disease].
001414 (1999) J L Montastruc ; M. Ziegler ; O. Rascol ; M. MalbezinA randomized, double-blind study of a skin patch of a dopaminergic agonist, piribedil, in Parkinson's disease.
001529 (1997) O. Moreaud ; N. Fournet ; J L Roulin ; B. Naegele ; J. PellatThe phonological loop in medicated patients with Parkinson's disease: presence of phonological similarity and word length effects.
001705 (1993) J L Montastruc ; O. Rascol ; J M SenardCurrent status of dopamine agonists in Parkinson's disease management.
001776 (1992) P. Rondot ; M. ZieglerActivity and acceptability of piribedil in Parkinson's disease: a multicentre study.
001777 (1992) C. Corbe ; F. Arnaud ; Y. Brault ; C. Janiak-BolzingerEffect of a dopaminergic agonist, piribedil (Trivastal 50 mg LP), on visual and spatial integration in elderly subjects.
001805 (1991) D. Milon ; H. Allain ; D. Bentue-Ferrer ; J P Martinet ; M H Lemaitre ; R. DecombeCardiac beta-adrenoceptor sensitivity and Parkinson's disease.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PubMed/Corpus
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/MedMesh.i -k "Piribedil" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/MedMesh.i  \
                -Sk "Piribedil" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Piribedil
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024